Aberrant NLRP3 inflammasome activation contributes to diverse inflammatory disorders, including sepsis, CAPS, peritonitis, atherosclerosis, and experimental autoimmune encephalomyelitis (EAE), underscoring its therapeutic relevance. The gene discussed is NLRP3; the disease is experimental autoimmune encephalomyelitis.